Async Doctor
Discovery Lens
C Combination Innovation
Two separate worlds finally connect — and the intersection is a product
One-Liner
A platform where patients submit health concerns (symptoms + photos + voice + wearable data), AI pre-processes into a structured clinical package, and doctors review and respond asynchronously — turning 15-minute visits into 2-minute reviews.
Kill Reason
Asynchronous telehealth faces a compounding stack of regulatory barriers: state-level physician licensing requirements, insurance reimbursement rules that require synchronous consultation for most billable services, and HIPAA compliance infrastructure costs that favor existing EHR vendors. Epic, athenahealth, and Teladoc already serve this market with compliant, integrated platforms.
What do you think?
Related ideas you can explore free:
killed: Urine and stool analysis for glucose monitoring, cancer screening, and kidney function markers falls squarely into FDA Class II/III medical device territory, requiring clinical trials and 510(k) or PMA approval costing millions and taking years. The entire high-value use case — the reason anyone would buy this — is legally undeliverable without regulatory clearance the product cannot realistically obtain.
killed: Amazon Alexa Together and comparable remote family monitoring services already serve this exact use case at consumer price points with embedded distribution advantages that a standalone WiFi sensing module cannot overcome. Daily routine monitoring and anomaly alerting for elderly relatives is a feature, not a product, in the current competitive landscape.
killed: Personal injury narrative reports require specific medico-legal structure, but the format is well-documented in public templates and any chiropractor with a configured AI prompt can replicate the output — there is no proprietary data asset, workflow lock-in, or network effect to justify a subscription fee against a commodity capability.